# Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria-draft-guidance-for-industry/1eea49f3-76b0-45d6-81c4-4a91e8a41311

> FDA guidance document: Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry. Issue date: January 15, 2025. Get complete insights and analysis.

---

## Details

- Title: Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2025-01-15
- Last Changed: 2025-01-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2000-D-0187">FDA-2000-D-0187</a>

## Related Documents

- [Potency Assurance for Cellular and Gene Therapy Products](https://www.globalkeysolutions.net/guidances/guidance-document/potency-assurance-for-cellular-and-gene-therapy-products/2a9b0d81-9dd5-43cf-994c-ac0df102c216)
- [Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-determining-eligibility-of-donors-of-human-cells-tissues-and-cellular-and-tissue-based-products-hctps-draft-guidance-for-industry/34d3fa14-1a2f-4058-96a0-b008d076762a)
- [Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products](https://www.globalkeysolutions.net/guidances/guidance-document/manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products/b4919edd-67a6-490a-ab51-aa1a3c93944e)